Concepedia

Isabelle Fleury

IF

Statistics

Publications

33

Citations

5.7K

H-Index

21

Active since

2003

Affiliations

Hôpital Maisonneuve-Rosemont(Current)

Université de Montréal

Medical University of Vienna

University of Chicago

University Hospital Cologne

Isabelle Fleury is an author at Hôpital Maisonneuve-Rosemont specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

2003–2025

33

Publications

33

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster, Michael Bishop, Constantine S. Tam et al. · New England Journal of Medicine · 2018 · 4K citations · Full text

, , +15

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

Stephen J. Schuster, Constantine S. Tam, Peter Borchmann et al. · The Lancet Oncology · 2021 · 561 citations

, , +9

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Franck Morschhauser, Saurabh Dahiya, M. Lia Palomba et al. · Nature Medicine · 2024 · 130 citations · Full text

, , +16

Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec

Vanessa Brunet, Sofia Marouan, Jean‐Pierre Routy et al. · Medicine · 2017 · 102 citations · Full text

, , +11

Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion

Michael Bishop, Richard T. Maziarz, Edmund K. Waller et al. · Blood Advances · 2019 · 86 citations · Full text

, , +12

1–5 of 33